Developmental Expression of Transforming Growth Factor Induced Protein Promotes NF-Kappa-B Mediated Angiogenesis During Postnatal Lung Development
M. Liu, Cristiana IosefiD, Shailaja P. Rao, Racquel Domingo-GonzaleziD, Sha FuiD, Paige L. Snider, Simon James ConwayiD, Gray S. UmbachiD, Sarah C. HeilshorniD, Ruby E. Dewi, Mar Janna DahliD, Donald M. NulliD, Kurt H. AlbertineiD, Cristina M. AlviraiD
Abstract
RationalePulmonary angiogenesis is a key driver of alveolarization. Our prior studies showed that nuclear factor kappa-B (NF{kappa}B) promotes pulmonary angiogenesis during early alveolarization. However, the mechanisms regulating temporal-specific NF{kappa}B activation in the pulmonary vasculature are unknown. ObjectivesTo identify mechanisms that activate pro-angiogenic NF{kappa}B signaling in the developing pulmonary vasculature. MethodsProteomic analysis of the lung secretome was performed using 2D-DIGE. NF{kappa}B activation and angiogenic function was assessed in primary pulmonary endothelial cells (PEC) and TGFBI-regulated genes identified using RNA-sequencing. Alveolarization and pulmonary angiogenesis was assessed in WT and TGFBI null mice exposed to normoxia or hyperoxia. Lung TGFBI expression was determined in premature lambs supported by invasive and noninvasive respiratory support. Measurements and Main ResultsSecreted factors from the early alveolar, but not the late alveolar or adult lung, promoted proliferation and migration in quiescent, adult PEC. Proteomic analysis identified transforming growth factor beta-induced protein (TGFBI) as a protein highly expressed by myofibroblasts in the early alveolar lung that promoted PEC migration by activating NF{kappa}B via v{beta}3 integrins. RNA-sequencing identified Csf3 as a TGFBI-regulated gene that enhances nitric oxide production in PEC. Loss of TGFBI in mice exaggerated the impaired pulmonary angiogenesis induced by chronic hyperoxia, and TGFBI expression was disrupted in premature lambs with impaired alveolarization. ConclusionsOur studies identify TGFBI as a developmentally-regulated protein that promotes NF{kappa}B-mediated angiogenesis during early alveolarization by enhancing nitric oxide production. We speculate that dysregulation of TGFBI expression may contribute to diseases marked by impaired alveolar and vascular growth.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Natural killer cell TGF- signaling regulates senolytic activity and vascular patterning in the postnatal lung
Declan J. Gainer, Kassandra M. Coyle, … Mark L. Ormiston·Circulation ResearchPeer-reviewed·Oct 27, 2026
- Neonatal regulatory T cells promote alveologenesis by restraining neutrophil-mediated inflammation
Monica Sen, Prudence PokWai Lui, … Niwa Ali·bioRxiv·Mar 25, 2026
- Overactivated epithelial NF-κB disrupts lung development in human and nitrofen CDH
Florentine Dylong, Jan Riedel, … Richard Wagner·bioRxiv·Apr 7, 2023
- MicroRNA-214 prevents pulmonary angiogenesis and alveolarization in rat models with hyperoxia-mediated impairment of lung development by blocking PlGF-dependent STAT3 signaling pathway
- Pericytes enable effective angiogenesis in the presence of pro inflammatory signals
Tae-Yun Kang, Federico Bocci, … Andre Levchenko·Proceedings of the National Academy of SciencesPeer-reviewed·Nov 4, 2019
- Ubiquitin-specific peptidase 20 constrains endothelial cell activation and angiogenic sprouting through NF-κB inhibition
Bipradas Roy, Jiao‐Hui Wu, … Sudha K. Shenoy·bioRxiv·May 20, 2025